Oxford BioMedica PLC (OXBDF)

[georgejjl]

The Jenner Institute at Oxford University made the headlines this week as it could have a few million doses ready as early as September.

A US study showed that monkeys which were administered the Oxford vaccine survived exposure to the virus and were healthy four weeks after receiving the jab.

Although immunity in monkeys does not necessarily ensure the same will happen in humans, the results are encouraging as the team prepare to test 6,000 people by the end of May.

The university also signed a deal with AstraZeneca PLC (LON:AZN), which will produce and distribute the vaccine if and when it is approved, on a not-for-profit basis for the duration of the coronavirus pandemic.

Biotech firm Oxford Biomedica PLC (LON:OXB) is also involved in the production.

Ironically, flattening the curve of coronavirus cases in the UK comes as a challenge.

“We’re the only people in the country who want the number of new infections to stay up for another few weeks, so we can test our vaccine,” Prof. Adrian Hill, the Jenner Institute’s director, told the New York Times.

Researchers are not allowed to infect test participants with a serious disease: the only way to prove whether a vaccine is successful is to have trials in an area where the virus is widespread.

https://www.proactiveinvestors.co.uk/companies/news/918330/the-four-coronavirus-vaccine-candidates-to-watch-918330.html

Good luck and GOD bless,